Combination chemotherapy: synergistic inhibition of lymphoma L5178Y cells in culture and in vivo with 6-mercaptopurine and 6-(methylmercapto)purine ribonucleoside.
D000818:Animals; D004357:Drug Synergism; D008223:Lymphoma / Q000188:drug therapy* / Q000401:mortality; D015122:Mercaptopurine / Q000008:administration & dosage*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009705:Nucleosides / Q000008:administration & dosage*; D013997:Time Factors
D009705:Nucleosides; D015122:Mercaptopurine